KDR and osteosarcoma: Apatinib is a highly selective tyrosine kinase inhibitor to VEGFR2, which exerts promising antitumoral effect in various tumors.23, 24 This research demonstrates the antitumoral effects of Apatinib on osteosarcoma cells in vitro and in vivo.